Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -71.86%.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-40.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-157.39%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PMGC Holdings Inc.
Market Cap
$1.49M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-40.34%
3Y Avg
-157.39%
5Y Avg
N/A
Market Cap
$1.54M
Return on Invested Capital (ROIC)
-567.17%
TTM Avg
-332.51%
3Y Avg
-201.53%
5Y Avg
-141.19%
Market Cap
$1.37M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.36M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$1.17M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
Market Cap
$1.14M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.11M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.92M
Return on Invested Capital (ROIC)
-518.15%
TTM Avg
-216.02%
3Y Avg
-220.11%
5Y Avg
-314.84%
Market Cap
$1.02M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | $1.49M | N/A | -40.34% | -157.39% | N/A |
| Curis, Inc. (CRIS)vs › | $1.54M | -567.17% | -332.51% | -201.53% | -141.19% |
| Genprex, Inc. (GNPX)vs › | $1.37M | -107.08% | -750.62% | -506.81% | -355.90% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -219.36% | -214.97% | -160.97% | -133.06% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -128.95% | -69.60% | -67.51% | -50.89% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -9.45% | -4.19% | 5.39% | 5.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -60.41% | -162.02% | -321.37% | -223.75% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | -518.15% | -216.02% | -220.11% | -314.84% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -59.81% | -3.58% | -5.96% | -5.96% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | -343.55% | -272.49% | -270.70% | -191.72% |
ROIC
N/A
ROE
-80.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -71.86% |
| 2025-09-30 | -31.46% |
| 2025-06-30 | -30.75% |
| 2025-03-31 | -28.60% |
| 2024-12-31 | -39.02% |
| 2024-09-30 | -46.65% |
| 2024-06-30 | -105.37% |
| 2024-03-31 | -91.79% |
| 2023-12-31 | -49.34% |
| 2023-06-30 | -1099.13% |
| 2022-12-31 | -137.31% |